Laurell A - Search Results

1

Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation.

Walsh SH, Laurell A, Sundström G, Roos G, Sundström C, Rosenquist R. Walsh SH, et al. Among authors: laurell a. Leuk Res. 2005 Jul;29(7):729-34. doi: 10.1016/j.leukres.2004.12.008. Epub 2005 Feb 16. Leuk Res. 2005. PMID: 15927667

2

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.

Tobin G, Thunberg U, Karlsson K, Murray F, Laurell A, Willander K, Enblad G, Merup M, Vilpo J, Juliusson G, Sundström C, Söderberg O, Roos G, Rosenquist R. Tobin G, et al. Among authors: laurell a. Blood. 2004 Nov 1;104(9):2879-85. doi: 10.1182/blood-2004-01-0132. Epub 2004 Jun 24. Blood. 2004. PMID: 15217826 Free article.

3

Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes.

Thelander EF, Walsh SH, Thorsélius M, Laurell A, Landgren O, Larsson C, Rosenquist R, Lagercrantz S. Thelander EF, et al. Among authors: laurell a. Mod Pathol. 2005 Mar;18(3):331-9. doi: 10.1038/modpathol.3800237. Mod Pathol. 2005. PMID: 15257315 Free article.

4

VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.

Aleskog A, Tobin G, Laurell A, Thunberg U, Lindhagen E, Roos G, Nilsson K, Nygren P, Sundström C, Höglund M, Larsson R, Rosenquist R. Aleskog A, et al. Among authors: laurell a. Eur J Haematol. 2004 Dec;73(6):407-11. doi: 10.1111/j.1600-0609.2004.00334.x. Eur J Haematol. 2004. PMID: 15522062

5

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.

Grabowski P, Hultdin M, Karlsson K, Tobin G, Aleskog A, Thunberg U, Laurell A, Sundström C, Rosenquist R, Roos G. Grabowski P, et al. Among authors: laurell a. Blood. 2005 Jun 15;105(12):4807-12. doi: 10.1182/blood-2004-11-4394. Epub 2005 Mar 3. Blood. 2005. PMID: 15746080 Free article.

6

Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia.

Tobin G, Skogsberg A, Thunberg U, Laurell A, Aleskog A, Merup M, Sundström C, Roos G, Nilsson K, Rosenquist R. Tobin G, et al. Among authors: laurell a. Leukemia. 2005 May;19(5):871-3. doi: 10.1038/sj.leu.2403715. Leukemia. 2005. PMID: 15759030 No abstract available.

7

Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.

Tobin G, Thunberg U, Laurell A, Karlsson K, Aleskog A, Willander K, Söderberg O, Merup M, Vilpo J, Hultdin M, Sundström C, Roos G, Rosenquist R. Tobin G, et al. Among authors: laurell a. Haematologica. 2005 Apr;90(4):465-9. Haematologica. 2005. PMID: 15820941

8

The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia.

Skogsberg S, Tobin G, Kröber A, Kienle D, Thunberg U, Aleskog A, Karlsson K, Laurell A, Merup M, Vilpo J, Sundström C, Roos G, Jernberg-Wiklund H, Döhner H, Nilsson K, Stilgenbauer S, Rosenquist R. Skogsberg S, et al. Among authors: laurell a. Leukemia. 2006 Jan;20(1):77-81. doi: 10.1038/sj.leu.2404030. Leukemia. 2006. PMID: 16307023

9

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.

Thorsélius M, Kröber A, Murray F, Thunberg U, Tobin G, Bühler A, Kienle D, Albesiano E, Maffei R, Dao-Ung LP, Wiley J, Vilpo J, Laurell A, Merup M, Roos G, Karlsson K, Chiorazzi N, Marasca R, Döhner H, Stilgenbauer S, Rosenquist R. Thorsélius M, et al. Among authors: laurell a. Blood. 2006 Apr 1;107(7):2889-94. doi: 10.1182/blood-2005-06-2227. Epub 2005 Nov 29. Blood. 2006. PMID: 16317103 Free article.

10

Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14).

Adde M, Enblad G, Hagberg H, Sundström C, Laurell A. Adde M, et al. Among authors: laurell a. Med Oncol. 2006;23(2):283-93. doi: 10.1385/MO:23:2:283. Med Oncol. 2006. PMID: 16720929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters